InvestorsHub Logo
Followers 466
Posts 26932
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 2085

Wednesday, 03/02/2011 9:17:56 AM

Wednesday, March 02, 2011 9:17:56 AM

Post# of 3753
8:49AM Marina Biotech announces significant knockdown of a cancer target in a rodent model of malignant ascites (MRNA) 0.68 : Co reports data demonstrating significant knockdown of target mRNA in an orthotopic model of malignant ascites with its proprietary UsiRNA construct and DiLA2-based delivery system. The data were presented by Michael V. Templin, Ph.D., Senior Vice President, Preclinical Development at Marina Biotech, Inc., at Asia TIDES Oligonucleotides and Peptides Research Technology and Product Development March 2 - 4, 2011 in Tokyo, Japan.


surf's up......crikey



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ATRX News